Prof. MD. Fikret Arpacı

Prof. MD.

Fikret Arpacı

Liv Hospital Ankara
Medical Oncology
Single Form Doctors
Prof. MD. Fikret Arpacı

Prof. MD.

Fikret Arpacı

Liv Hospital Ankara
Medical Oncology
Single Form Doctors

Areas of Interests

  • High Dose Chemotherapy
  • Bone Marrow (Stem Cell) Transplantation 
  • (Autologous, Allogeneic, Haploidentic) 
  • Lymphoma, Leukemia, Breast, Lung, Colon, Stomach and Other Cancers
27

h-index

Education

  • University of South Carolina, Department of Transplantation (1995-1996)
  • War Academy Dispensary (1985-1987)
  • GATA Faculty of Medicine (1984)
  • Istanbul University Faculty of Medicine (1978-1983)
Experience
  • Liv Hospital Ankara 2014
  • Medical Oncology
  • Bone Marrow Transplant
  • GATA Medical Oncology and Bone Marrow Transplant Center (1992-2014)
  • GATA Internal Medicine (1987-1991)
  • Sarıkamış Military Hospital (1992)
  •  
  • International Article:91
    National Article 92
    International Article Refereeing: 11
    International Conference Presentation: 3
    International Congress Session Chair: 2
    International Paper – Poster: 131
    National Paper – Oral – Poster: 233
    Book (Turkish) Editor: 1
    Book Chapter (Turkish): 10
    Book (International) Chapter: 2International Article:91
    National Article 92
    International Article Refereeing: 11
    International Conference Presentation: 3
    International Congress Session Chair: 2
    International Paper – Poster: 131
    National Paper – Oral – Poster: 233
    Book (Turkish) Editor: 1
    Book Chapter (Turkish): 10
    Book (International) Chapter: 2International Article:91
    National Article 92
    International Article Refereeing: 11
    International Conference Presentation: 3
    International Congress Session Chair: 2
    International Paper – Poster: 131
    National Paper – Oral – Poster: 233
    Book (Turkish) Editor: 1
    Book Chapter (Turkish): 10
    Book (International) Chapter: 2International Article:91
    National Article 92
    International Article Refereeing: 11
    International Conference Presentation: 3
    International Congress Session Chair: 2
    International Paper – Poster: 131
    National Paper – Oral – Poster: 233
    Book (Turkish) Editor: 1
    Book Chapter (Turkish): 10
    Book (International) Chapter: 2
  • International Article:91
  • National Article 92
  • International Article Refereeing: 11
  • International Conference Presentation: 3
  • International Congress Session Chair: 2
  • International Paper – Poster: 131
  • National Paper – Oral – Poster: 233
  • Book (Turkish) Editor: 1
  • Book Chapter (Turkish): 10
  • Book (International) Chapter: 2
  • The relationship between disease features and quality of life in patients with cancer—I
  • V Isikhan, P Güner, S Kömürcü, A Özet, F Arpaci, B Öztürk
  • Cancer nursing 24 (6), 490-495
  • 197      2001
  • Patients’ preferences for subcutaneous trastuzumab versus conventional intravenous infusion for the adjuvant treatment of HER2-positive early breast cancer: final analysis of …
  • X Pivot, J Gligorov, V Müller, G Curigliano, A Knoop, S Verma, V Jenkins, …
  • Annals of oncology 25 (10), 1979-1987
  • 194      2014
  • Serum copper and zinc levels and copper/zinc ratio in patients with breast cancer
  • I Yücel, F Arpaci, A Özet, B Döner, T Karayilanoĝlu, A Sayar, Ö Berk
  • Biological trace element research 40, 31-38
  • 155      1994
  • Hematopoietic stem cell transplantation in patients with gain-of-function signal transducer and activator of transcription 1 mutations
  • JW Leiding, S Okada, D Hagin, M Abinun, A Shcherbina, DN Balashov, …
  • Journal of Allergy and Clinical Immunology 141 (2), 704-717. e5
  • 153      2018
  • Development of rational in vitro models for drug resistance in breast cancer and modulation of MDR by selected compounds
  • MD Kars, ÖD Işeri, U Gündüz, AU Ural, F Arpaci, J Molnár
  • Anticancer Research 26 (6B), 4559-4568
  • 149      2006
  • Drug resistant MCF-7 cells exhibit epithelial-mesenchymal transition gene expression pattern
  • ÖD Işeri, MD Kars, F Arpaci, C Atalay, I Pak, U Gündüz
  • Biomedicine & Pharmacotherapy 65 (1), 40-45
  • 141      2011
  • Effects of tamoxifen on the serum leptin level in patients with breast cancer
  • A Ozet, F Arpaci, MI Yilmaz, H Ayta, B Ozturk, S Komurcu, AA Yavuz, …
  • Japanese journal of clinical oncology 31 (9), 424-427
  • 120      2001
  • Transplantation of allogeneic hematopoietic stem cells: an emerging treatment modality for solid tumors
  • T Demirer, L Barkholt, D Blaise, P Pedrazzoli, M Aglietta, AM Carella, …
  • Nature clinical practice Oncology 5 (5), 256-267
  • 105      2008
  • Gene expression analysis of drug-resistant MCF-7 cells: implications for relation to extracellular matrix proteins
  • ÖD Işeri, MD Kars, F Arpaci, U Gündüz
  • Cancer chemotherapy and pharmacology 65, 447-455
  • 93        2010
  • Low serum leptin level in colon cancer patients without significant weight loss
  • F Arpaci, MI Yilmaz, A Ozet, H Ayta, B Ozturk, S Komurcu, M Ozata
  • Tumori Journal 88 (2), 147-149
  • 77        2002
  • Cumulative prior dose of cisplatin as a cause of the nephrotoxicity of highdose chemotherapy followed by autologous stemcell transplantation
  • K Caglar, C Kinalp, F Arpaci, M Turan, K Saglam, B Ozturk, Ş Komurcu, …
  • Nephrology Dialysis Transplantation 17 (11), 1931-1935
  • 63        2002
  • Cerebellar aspergillosis: case report and literature review
  • E Erdogan, M Beyzadeoglu, F Arpaci, B Celasun
  • Neurosurgery 50 (4), 874-877
  • 62        2002
  • Reduced dose of lenograstim is as efficacious as standard dose of filgrastim for peripheral blood stem cell mobilization and transplantation: a randomized study in patients …
  • S Ataergin, F Arpaci, M Turan, L Solchaga, T Cetin, M Ozturk, A Ozet, …
  • American journal of hematology 83 (8), 644-648
  • 58        2008
  • Identification of polymorphisms on the MDR1 gene among Turkish population and their effects on multidrug resistance in acute leukemia patients
  • P Kaya, U Gündüz, F Arpaci, AU Ural, S Guran
  • American journal of hematology 80 (1), 26-34
  • 58        2005
  • Total parenteral nutrition delays platelet engraftment in patients who undergo autologous hematopoietic stem cell transplantation
  • T Çetin, F Arpaci, Y Dere, M Turan, B Öztürk, Ş Kömürcü, A Özet, …
  • Nutrition 18 (7-8), 599-603
  • 58        2002
  • The status of alternative treatment in cancer patients in Turkey
  • V Isikhan, S Komurcu, A Ozet, F Arpaci, B Ozturk, O Balbay, P Guner
  • Cancer Nursing 28 (5), 355-362
  • 54        2005
  • Quality of life and sociodemographic characteristics of patients with cancer in Turkey.
  • P Güner, V Isikhan, S Kömürcü, S Il, B Öztürk, F Arpaci, A Özet
  • Oncology nursing forum 33 (6)
  • 51        2006
  • Effect of dose-rate and lung dose in total body irradiation on interstitial pneumonitis after bone marrow transplantation
  • M Beyzadeoglu, K Oysul, B Dirican, F Arpaci, A Balkan, S Surenkok, …
  • The Tohoku journal of experimental medicine 202 (4), 255-263
  • 49        2004
  • Oxidative stress in patients undergoing high-dose chemotherapy plus peripheral blood stem cell transplantation
  • T Cetin, F Arpaci, MI Yilmaz, K Saglam, B Ozturk, S Komurcu, M Gunay, …
  • Biological trace element research 97, 237-247
  • 45        2004
  • Megestrol acetate for cachexia and anorexia in advanced non-small cell lung cancer: a randomized study comparing two different doses
  • HC Ulutin, F Arpaci, Y Pak
  • Tumori Journal 88 (4), 277-280
  • 44        2002
  • National survey of hemapheresis practice in Turkey (1998)
  • O Ilhan, N Üskent, Ö Arslan, M Arat, F Özkalemkaş, G Öztürk, …
  • Transfusion science 22 (3), 195-201
  • 37        2000
  • The feasibility of neoadjuvant highdose chemotherapy and autologous peripheral blood stem cell transplantation in patients with nonmetastatic high grade localized osteosarcoma …
  • F Arpaci, S Ataergin, A Ozet, K Erler, M Basbozkurt, A Ozcan, S Komurcu, …
  • Cancer: Interdisciplinary International Journal of the American Cancer …
  • 36        2005
  • GATA Tıbbi Onkoloji Bilim Dalı’nda izlenen hastaların bazı sosyodemografik özellikleri ve tanıları
  • S KILIÇ, Ş KÖMÜRCÜ, M RZAYEV, A ÖZET, T KIR, F ARPACI, …
  • Gülhane Tıp Dergisi 46 (2), 115-124
  • 36        2004
  • Efficacy of melatonin, mercaptoethylguanidine and 1400W in doxorubicinand trastuzumabinduced cardiotoxicity
  • M Ozturk, M Ozler, YG Kurt, B Ozturk, B Uysal, N Ersoz, M Yasar, …
  • Journal of Pineal Research 50 (1), 89-96
  • 35        2011
  • Transient efficacy of double high-dose chemotherapy and autologous peripheral stem cell transplantation, immunoglobulin, thalidomide, and bortezomib in the treatment of …
  • S Ataergin, F Arpaci, M Demiriz, A Ozet
  • American journal of clinical dermatology 9, 271-273
  • 30        2008
  • Colon cancer during pregnancy. A case report.
  • S Kömürcü, B Oztürk, F Arpaci, MK Altundağ, Y Tezcan
  • The Journal of Reproductive Medicine 46 (1), 75-78
  • 30        2001
  • Paraneoplastic motor neuron disease resembling amyotrophic lateral sclerosis in a patient with renal cell carcinoma
  • HM Turk, A Ozet, O Kuzhan, F Komurcu, F Arpaci, B Ozturk, S Ataergin
  • Medical Principles and Practice 18 (1), 73-75
  • 28        2008
  • Detection of widespread neurolymphomatosis with 18F-FDG PET
  • E Öztürk, F Arpaci, M Kocaoğlu, N Arslan, N Bulakbaşi, M Özgüven
  • European Journal of Nuclear Medicine and Molecular Imaging 33, 975-976
  • 27        2006
  • Selective intraarterial radionuclide therapy with Yttrium-90 (Y-90) microspheres for hepatic neuroendocrine metastases: initial experience at a single center
  • N Arslan, M Emi, E Alagöz, B Üstünsöz, K Oysul, F Arpacı, Ş Uğurel, …
  • Vojnosanitetski pregled 68 (4), 341-348
  • 21        2011
  • Bilateral male breast cancer and prostate cancer: a case report
  • A Özet, AA Yavuz, S Kömürcü, B Öztürk, M Safali, F Arpaci, Z Çaliskaner
  • Japanese Journal of Clinical Oncology 30 (4), 188-190
  • 21        2000
  • Turkish Transplant Registry: a comparative analysis of national activity with the EBMT European Activity Survey
  • M Arat, F Arpaci, M Ertem, G Gürman
  • Bone marrow transplantation 42 (1), S142-S145
  • 17        2008
  • A successful and simplified filgrastim primed single apheresis method without large volume apheresis for peripheral blood stem cell collection
  • F Arpaci, S Kömürcü, B Öztürk, A Özet, C Kinalp, A Sengül, …
  • Japanese Journal of Clinical Oncology 30 (3), 153-158
  • 17        2000
  • Modified outpatient dexamethazone, cytarabine and cisplatin regimen may lead to high response rates and low toxicity in lymphoma
  • O Kanat, A Ozet, S Ataergın, F Arpacı, O Kuzhan, S Komurcu, B Ozturk, …
  • Medical Principles and Practice 19 (5), 344-347
  • 16        2010
  • Factors affecting engraftment time in autologous peripheral stem cell transplantation
  • HM Turk, S Komurcu, F Arpaci, A Ozet, S Kilic, O Kuzhan, B Ozturk, …
  • Asian Pac J Cancer Prev 11 (3), 697-702
  • 16        2010
  • Self-reported experience of mucositis in cancer patients who underwent conditioning regimen and stem cell transplantation
  • M Ozturk, S Komurcu, S Kilic, A Ozet, F Arpaci, B Ozturk, O Kuzhan, …
  • Supportive care in cancer 17, 1295-1299
  • 16        2009
  • West Nile virus infection in a patient with acute graft-versus-host disease
  • F Arpaci, T Cetin, A Kubar, M Ozturk, O Kuzhan, S Komurcu, B Ozturk, …
  • HAEMATOLOGICA-THE HEMATOLOGY JOURNAL 94, 687-687
  • 16        2009
  • VAD combination chemotherapy followed by bortezomib may be an effective treatment in secondary plasma cell leukemia
  • S Ataergin, F Arpaci, A Kaya, T Kaya, O Gunhan
  • American journal of hematology 81 (12), 987-988
  • 16        2006
  • GCSFmobilized haploidentical peripheral blood stem cell transplantation in children with poor prognostic nonmalignant disorders
  • F Arpacı, I Tezcan, O Kuzhan, N Yalman, D Uçkan, AE Kürekçi, …
  • American journal of hematology 83 (2), 133-136
  • 13        2008
  • Donor cell leukemia in a patient developing 11 months after an allogeneic bone marrow transplantation for chronic myeloid leukemia
  • S Ataergin, F Arpaci, T Cetin, S Guran, C Yakicier, M Beyzadeoglu, A Ozet
  • American journal of hematology 81 (5), 370-373
  • 13        2006
  • Evaluation of fractionated total body irradiation and dose rate on cataractogenesis in bone marrow transplantation.
  • M Beyzadeoglu, B Dirican, K Oysul, F Arpaci, Y Pak
  • Haematologia 32 (1), 25-30
  • 13      &
  •  
  • Gülhane Medical Journal
  • Turkish Journal of Caner
  • Turkish Journal of Clinical Medical Sciences
  • Turkish Journal of Hematology
  • Turkish Journal of Hematology and Oncology
  • International Bone Marrow Transplant Center (IBMTR)
  • European Bone Marrow Transplant (EBMT)
  • European Society of Medical Oncology (ESMO)
  • Turkish Bone Marrow Registry (TTR)
  • Turkish Society of Medical Oncology (TTOD)
  • Turkish Hematology Association (THD)
  • Turkish Oncology Group (TOG)
  •  

Ask Our Experts

Doctors

Maximum file size: 209.72MB

Subscribe to Liv E-newsletter